Lancet

Intensive insulin provides survival

Long-term follow-up of the DIGAMI 1 trial – a landmark study of type 2 diabetes in Sweden – shows that intensive insulin treatment prolonged life by more than 2 years in patients with diabetes after a heart attack, compared ...

May 13, 2014
popularity not rated yet | comments 0

Promising biomarkers to predict suicide risk

In a Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Kees van Heeringen from Ghent University in Belgium and John Mann from Columbia University in the USA discuss the stress-diathesis theory ...

May 02, 2014
popularity not rated yet | comments 0